---
title: 'Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential
  Biomarkers, and Therapeutic Targets'
date: '2022-11-26'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/36430837/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1Zkrxt7ktlCbHBXEV3v65xxSnkSWNsJ1A6Fq3gBniKhGfIUslK&fc=20210907212339&ff=20221129201244&v=2.17.8
source: metablomics[MeSH Terms]
description: Clear cell renal cell carcinoma (ccRCC) is the most frequent histological
  kidney cancer subtype. Over the last decade, significant progress has been made
  in identifying the genetic and metabolic alterations driving ccRCC development.
  In particular, an integrated approach using transcriptomics, metabolomics, and lipidomics
  has led to a better understanding of ccRCC as a metabolic disease. The metabolic
  profiling of this cancer could help define and predict its behavior in terms of
  ...
---
Clear cell renal cell carcinoma (ccRCC) is the most frequent histological kidney cancer subtype. Over the last decade, significant progress has been made in identifying the genetic and metabolic alterations driving ccRCC development. In particular, an integrated approach using transcriptomics, metabolomics, and lipidomics has led to a better understanding of ccRCC as a metabolic disease. The metabolic profiling of this cancer could help define and predict its behavior in terms of ...